Trial Profile

A Phase II Study of sEphB4-HSA in Kaposi Sarcoma

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 17 Oct 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SEphB4-HSA (Primary)
Indications Kaposi's sarcoma
Focus Adverse reactions; Therapeutic Use
Sponsors VasGene Therapeutics

Most Recent Events

11 Oct 2022 Planned End Date changed from 1 Jun 2022 to 1 Jun 2025.
11 Oct 2022 Planned primary completion date changed from 1 Jun 2022 to 1 Dec 2024.
07 Oct 2020 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Dec 2019 to 1 Jan 2021.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com